Changmao Biochemical Engineering Co (HKSE:00954) Debt-to-Equity : 0.56 (As of Jun. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Changmao Biochemical Engineering Co Debt-to-Equity?

Changmao Biochemical Engineering Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$306.0 Mil. Changmao Biochemical Engineering Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$148.2 Mil. Changmao Biochemical Engineering Co's Total Stockholders Equity for the quarter that ended in Jun. 2023 was HK$811.5 Mil. Changmao Biochemical Engineering Co's debt to equity for the quarter that ended in Jun. 2023 was 0.56.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Changmao Biochemical Engineering Co's Debt-to-Equity or its related term are showing as below:

HKSE:00954' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.1 Max: 0.56
Current: 0.76

During the past 13 years, the highest Debt-to-Equity Ratio of Changmao Biochemical Engineering Co was 0.56. The lowest was 0.00. And the median was 0.10.

HKSE:00954's Debt-to-Equity is ranked worse than
76.88% of 1397 companies
in the Chemicals industry
Industry Median: 0.35 vs HKSE:00954: 0.76

Changmao Biochemical Engineering Co Debt-to-Equity Historical Data

The historical data trend for Changmao Biochemical Engineering Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changmao Biochemical Engineering Co Debt-to-Equity Chart

Changmao Biochemical Engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.03

0.13

0.37

0.76

Changmao Biochemical Engineering Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.13	0.33	0.37	0.56	0.76

Competitive Comparison of Changmao Biochemical Engineering Co's Debt-to-Equity

For the Specialty Chemicals subindustry, Changmao Biochemical Engineering Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Changmao Biochemical Engineering Co's Debt-to-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Changmao Biochemical Engineering Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Changmao Biochemical Engineering Co's Debt-to-Equity falls into.

Changmao Biochemical Engineering Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Changmao Biochemical Engineering Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(154.355	+	171.17)	/	869.397
	=	0.37

Changmao Biochemical Engineering Co's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(305.968	+	148.227)	/	811.48
	=	0.56

Changmao Biochemical Engineering Co (HKSE:00954) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Changmao Biochemical Engineering Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Changmao Biochemical Engineering Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Changmao Biochemical Engineering Co (HKSE:00954) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Changmao Biochemical Engineering Co Ltd (HKSE:00954) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1228 Chang Jiang Bei Road, New North Zone, Jiangsu Province, Changzhou City, CHN, 213034

Website

http://www.cmbec.com.hk

Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.

Changmao Biochemical Engineering Co (HKSE:00954) Headlines

No Headlines